Leading brokers name 3 ASX shares to buy today

Yesterday I took a quick look at a number of unfortunate shares which brokers had just slapped sell ratings on.

Today I thought I would look at shares which have found favour with brokers and have been given buy ratings. Here they are:

McPherson’s Ltd (ASX: MCP)

A research note out of Shaw and Partners yesterday revealed that its analysts have slapped a buy rating and $1.85 price target on the household and beauty products company’s shares. The broker appears to believe that McPherson’s is trading at a significant discount to its peers and could be rerated in the near future. While 10x trailing earnings is certainly cheap, the company does look likely to deliver a third successive year of sales declines in FY 2017. I’d prefer to invest in companies which are exhibiting strong sales growth.

Sigma Healthcare Ltd (ASX: SIG)

Credit Suisse has upgraded the pharmacy operator and supplier to an outperform rating with a 90 cents price target. According to the note the broker believes that the market has been overly negative on its legal action against Chemist Warehouse. Although it acknowledges that losing a contract with its major customer would be difficult, it sees opportunities for Sigma to reinvest freed up working capital in earnings accretive acquisitions. Although I agree with this view, I’m not convinced that Sigma’s shares have found their bottom yet. This could make it one to avoid.

Wesfarmers Ltd (ASX: WES)

According to a note out of Macquarie, its analysts have reiterated their outperform rating and $45.00 price target on Wesfarmers’ shares following a series of executive appointments. The broker appears confident that the new management team will ensure that the next few years are successful, delivering earnings growth and improved returns. At the current share price I think Wesfarmers is a good, but not great option for income investors.

Whereas I think this quality dividend share could be classed as a great option for income investors today. Its huge yield and strong growth prospects could arguably make it a must buy.

HOT OFF THE PRESSES: Motley Fool's #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this 'under the radar' consumer favourite is both a hot growth stock AND our expert's #1 dividend pick for 2017. Now we're pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is click the link below!

Simply click here to receive your copy of our brand-new FREE report, "The Motley Fool's Top Dividend Stock for 2017."

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.